ArticleCureus2025
Cavernous Sinus Dural Arteriovenous Fistula Initially Misdiagnosed As Ocular Myasthenia Gravis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cavernous sinus dural arteriovenous fistulas (CS-DAVF) can mimic ocular myasthenia gravis (OMG), as both may present with diplopia and ptosis. Differentiating between these conditions is critical because misdiagnosis can delay appropriate vascular treatment. Herein, we present the case of a 63-year-old woman who presented with a one-month history of diplopia and left-sided ptosis. Repeated edrophonium tests were positive, leading to an initial diagnosis of OMG. Immunotherapy led to a transient improvement, with decreased Myasthenia Gravis Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis scores. However, persistent diplopia and a new conjunctival injection raised the suspicion of CS-DAVF. Magnetic resonance imaging and angiography revealed enlargement of the left cavernous sinus, while digital subtraction angiography confirmed a left CS-DAVF. This case demonstrates the diagnostic challenges in distinguishing OMG from CS-DAVF. Even when clinical findings and bedside tests strongly suggest OMG, atypical ocular signs, such as conjunctival injection or chemosis, should prompt consideration of CS-DAVF. Careful interpretation of edrophonium results and timely neuroimaging are essential to avoid misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.